First National Bank of Mount Dora Trust Investment Services Cuts Stake in The Clorox Company (NYSE:CLX)

First National Bank of Mount Dora Trust Investment Services reduced its holdings in The Clorox Company (NYSE:CLX - Free Report) by 55.6% during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 2,932 shares of the company's stock after selling 3,666 shares during the period. First National Bank of Mount Dora Trust Investment Services' holdings in Clorox were worth $478,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. Innealta Capital LLC acquired a new stake in shares of Clorox during the 2nd quarter worth about $30,000. Trifecta Capital Advisors LLC boosted its stake in shares of Clorox by 139.8% in the second quarter. Trifecta Capital Advisors LLC now owns 223 shares of the company's stock valued at $30,000 after buying an additional 130 shares during the period. First Foundation Advisors bought a new stake in shares of Clorox in the first quarter valued at approximately $31,000. Family Firm Inc. acquired a new stake in Clorox during the second quarter worth approximately $31,000. Finally, Quarry LP increased its stake in Clorox by 99.1% during the 2nd quarter. Quarry LP now owns 229 shares of the company's stock worth $31,000 after acquiring an additional 114 shares during the period. 78.53% of the stock is owned by institutional investors.

Clorox Stock Performance

Clorox stock traded down $0.63 during mid-day trading on Monday, reaching $162.48. 1,204,285 shares of the company's stock were exchanged, compared to its average volume of 1,243,798. The company has a quick ratio of 0.63, a current ratio of 1.00 and a debt-to-equity ratio of 11.08. The firm has a market capitalization of $20.11 billion, a PE ratio of 56.61, a P/E/G ratio of 3.09 and a beta of 0.41. The Clorox Company has a one year low of $125.46 and a one year high of $169.09. The business's fifty day simple moving average is $161.63 and its 200 day simple moving average is $146.33.

Clorox (NYSE:CLX - Get Free Report) last posted its quarterly earnings results on Wednesday, October 30th. The company reported $1.86 EPS for the quarter, topping analysts' consensus estimates of $1.36 by $0.50. The company had revenue of $1.76 billion for the quarter, compared to analysts' expectations of $1.64 billion. Clorox had a net margin of 4.78% and a return on equity of 316.08%. Clorox's revenue was up 27.0% on a year-over-year basis. During the same quarter in the previous year, the firm posted $0.49 EPS. On average, sell-side analysts expect that The Clorox Company will post 6.79 earnings per share for the current year.

Clorox Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Thursday, November 7th. Shareholders of record on Wednesday, October 23rd will be paid a $1.22 dividend. The ex-dividend date is Wednesday, October 23rd. This represents a $4.88 annualized dividend and a yield of 3.00%. Clorox's dividend payout ratio is currently 170.04%.

Insider Buying and Selling at Clorox

In other news, EVP Angela C. Hilt sold 1,733 shares of Clorox stock in a transaction dated Friday, September 6th. The stock was sold at an average price of $165.52, for a total transaction of $286,846.16. Following the completion of the sale, the executive vice president now owns 13,471 shares in the company, valued at approximately $2,229,719.92. This trade represents a 0.00 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. Insiders own 0.57% of the company's stock.

Wall Street Analyst Weigh In

Several analysts recently issued reports on CLX shares. Citigroup increased their price target on shares of Clorox from $165.00 to $170.00 and gave the stock a "neutral" rating in a research report on Friday, September 6th. Evercore ISI lowered their target price on Clorox from $140.00 to $139.00 and set an "underperform" rating for the company in a report on Monday, October 14th. Barclays lifted their price target on Clorox from $137.00 to $139.00 and gave the company an "underweight" rating in a research note on Friday. BNP Paribas upgraded Clorox to a "strong sell" rating in a research report on Friday, September 6th. Finally, DA Davidson boosted their target price on shares of Clorox from $153.00 to $171.00 and gave the company a "neutral" rating in a report on Monday. Six research analysts have rated the stock with a sell rating, nine have given a hold rating and one has issued a buy rating to the stock. According to MarketBeat.com, the stock has a consensus rating of "Hold" and a consensus price target of $151.57.

About Clorox

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.